Literature DB >> 34497109

Gene Expression Profiling in Kidney Transplant Recipients on Immune Checkpoint Inhibitors: More than Meets the Eye.

Priyanka Jethwani1,2, Anushree C Shirali3.   

Abstract

Entities:  

Keywords:  acute allograft rejection; acute interstitial nephritis; gene expression profiling; immune checkpoint inhibitors; kidney transplantation

Mesh：

Substances：

Year:  2021        PMID： 34497109      PMCID： PMC8729569          DOI： 10.2215/CJN.09860721

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection.

Authors:  Benjamin M Tang; Maryam Shojaei; Grant P Parnell; Stephen Huang; Marek Nalos; Sally Teoh; Kate O'Connor; Stephen Schibeci; Amy L Phu; Anand Kumar; John Ho; Adrienne F A Meyers; Yoav Keynan; Terry Ball; Amarnath Pisipati; Aseem Kumar; Elizabeth Moore; Damon Eisen; Kevin Lai; Mark Gillett; Robert Geffers; Hao Luo; Fahad Gul; Jens Schreiber; Sandra Riedel; David Booth; Anthony McLean; Klaus Schughart
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

Review 2.  Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Authors:  Mark A Perazella; Anushree C Shirali
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

3.  Interferon-alpha-induced acute renal allograft rejection.

Authors:  M Magnone; J L Holley; R Shapiro; V Scantlebury; J McCauley; M Jordan; C Vivas; T Starzl; J P Johnson
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

4.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

5.  Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Authors:  Frank B Cortazar; Kristen A Marrone; Megan L Troxell; Kenneth M Ralto; Melanie P Hoenig; Julie R Brahmer; Dung T Le; Evan J Lipson; Ilya G Glezerman; Jedd Wolchok; Lynn D Cornell; Paul Feldman; Michael B Stokes; Sarah A Zapata; F Stephen Hodi; Patrick A Ott; Michifumi Yamashita; David E Leaf
Journal:  Kidney Int       Date:  2016-06-07       Impact factor: 10.612

6.  Immunological differences between primary and metastatic breast cancer.

Authors:  B Szekely; V Bossuyt; X Li; V B Wali; G A Patwardhan; C Frederick; A Silber; T Park; M Harigopal; V Pelekanou; M Zhang; Q Yan; D L Rimm; G Bianchini; C Hatzis; L Pusztai
Journal:  Ann Oncol       Date:  2018-11-01       Impact factor: 32.976

7.  A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.

Authors:  Naoka Murakami; Patrick Mulvaney; Melissa Danesh; Ala Abudayyeh; Adi Diab; Noha Abdel-Wahab; Maen Abdelrahim; Pascale Khairallah; Shayan Shirazian; Aleksandra Kukla; Itunu O Owoyemi; Tarek Alhamad; Samir Husami; Madhav Menon; Andrew Santeusanio; Christopher D Blosser; Sandra Carias Zuniga; Maria Jose Soler; Francesc Moreso; Zain Mithani; David Ortiz-Melo; Edgar A Jaimes; Victoria Gutgarts; Erik Lum; Gabriel M Danovitch; Francesca Cardarelli; Reed E Drews; Claude Bassil; Jennifer L Swank; Scott Westphal; Roslyn B Mannon; Keisuke Shirai; Abhijat Kitchlu; Song Ong; Shana M Machado; Suraj S Mothi; Patrick A Ott; Osama Rahma; F Stephen Hodi; Meghan E Sise; Shruti Gupta; David E Leaf; Craig E Devoe; Rimda Wanchoo; Vinay V Nair; Chrysalyne D Schmults; Glenn J Hanna; Ben Sprangers; Leonardo V Riella; Kenar D Jhaveri
Journal:  Kidney Int       Date:  2020-12-24       Impact factor: 18.998

8.  Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival.

Authors:  Kun-Chun Chiang; Sheng-Teng Huang; Ren-Chin Wu; Shih-Chiang Huang; Ta-Sen Yeh; Ming-Huang Chen; Jun-Te Hsu; Li-Wei Chen; Sheng-Fong Kuo; Ho-Yen Chueh; Horng-Heng Juang; Shuen-Iu Hung; Chun-Nan Yeh; Jong-Hwei S Pang
Journal:  Cancer Manag Res       Date:  2019-02-28       Impact factor: 3.989

9.  Antiviral Activity of Interferon Alpha-Inducible Protein 27 Against Hepatitis B Virus Gene Expression and Replication.

Authors:  Hafiz Ullah; Muhammad Sajid; Kun Yan; Jiangpeng Feng; Miao He; Muhammad Adnan Shereen; Qiaohong Li; Tianmo Xu; Ruidong Hao; Deyin Guo; Yu Chen; Limin Zhou; Li Zhou
Journal:  Front Microbiol       Date:  2021-03-31       Impact factor: 5.640

10.  Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor-Associated Adverse Events.

Authors:  Benjamin A Adam; Naoka Murakami; Graeme Reid; Katie Du; Ruqaya Jasim; Christie L Boils; Lihong Bu; Peter D Hill; Allan G Murray; Karine Renaudin; Candice Roufosse; Astrid Weins; Kevin Wen; Leonardo V Riella; Michael Mengel
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-09       Impact factor: 10.614
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.